Rights and permissions
About this article
Cite this article
Focus on cost-effectiveness, utility studies `could be a mistake'. Pharmacoecon. Outcomes News 364, 3–4 (2002). https://doi.org/10.1007/BF03279105
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03279105